SLC18A2 and Parkinson disease: In contrast to our analyses (Fig. 3b and Supplementary Table 1), a longitudinal PET study for VMAT2 availability estimated that PD patients with younger AAO may have prolonged dopaminergic degeneration in the premotor stage, and showed a lower radiotracer uptake and slower reduction rate in the motor phase3.